154 related articles for article (PubMed ID: 31576111)
21. ent-Sauchinone as Potential Anticancer Agent Inhibiting Migration and Invasion of Human Liver Cancer Cells via Suppressing the STAT3 Signaling Pathway.
Gong QZ; Xiao D; Feng F; Wen XD; Qu W
Chem Biodivers; 2018 Apr; 15(4):e1800024. PubMed ID: 29495104
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues.
Chen L; Xie YZ; Luo ZY; Liu LJ; Zou ZZ; Liu HD; Kong FR; Hao Y; Gao JL; Wang LL; Ma DY; Liu SY
Bioorg Med Chem Lett; 2020 Aug; 30(16):127286. PubMed ID: 32631508
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Molecular Docking Study of Novel 3-Cyanopyridine Derivatives for the Anti-Cancer Drug Target Survivin Protein.
Lu JH; Lai WJ; Jiang LH; Lei FH; Shen LQ; Wu AQ
Med Chem; 2023; 19(3):246-262. PubMed ID: 36043763
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
25. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract][Full Text] [Related]
26. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
[TBL] [Abstract][Full Text] [Related]
27. Discovery, synthesis, and evaluation of small-molecule signal transducer and activator of transcription 3 inhibitors.
Shi ZB; Zhao D; Huang YY; Du Y; Cao XR; Gong ZN; Zhao R; Li JX
Chem Pharm Bull (Tokyo); 2012; 60(12):1574-80. PubMed ID: 23207637
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-κB and STAT3 inhibitors.
Zeng B; Cheng Y; Zheng K; Liu S; Shen L; Hu J; Li Y; Pan X
Bioorg Chem; 2021 Jun; 111():104973. PubMed ID: 34004586
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and
Oleksak P; Psotka M; Vancurova M; Sapega O; Bieblova J; Reinis M; Rysanek D; Mikyskova R; Chalupova K; Malinak D; Svobodova J; Andrys R; Rehulkova H; Skopek V; Ngoc Lam P; Bartek J; Hodny Z; Musilek K
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):410-424. PubMed ID: 33440995
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives.
Metwally NH; Deeb EA
Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077
[TBL] [Abstract][Full Text] [Related]
31. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
32. Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3).
Chen H; Yang Z; Ding C; Xiong A; Wild C; Wang L; Ye N; Cai G; Flores RM; Ding Y; Shen Q; Zhou J
Eur J Med Chem; 2014 Jul; 82():195-203. PubMed ID: 24904966
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and anticancer activity of 2-arylimidazo[1,2-a]pyridinyl-3-amines.
Yadav UP; Ansari AJ; Arora S; Joshi G; Singh T; Kaur H; Dogra N; Kumar R; Kumar S; Sawant DM; Singh S
Bioorg Chem; 2022 Jan; 118():105464. PubMed ID: 34785441
[TBL] [Abstract][Full Text] [Related]
34. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
Gao D; Jin N; Fu Y; Zhu Y; Wang Y; Wang T; Chen Y; Zhang M; Xiao Q; Huang M; Li Y
Eur J Med Chem; 2021 Apr; 216():113333. PubMed ID: 33689932
[TBL] [Abstract][Full Text] [Related]
35. Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells.
Kim YH; Yoon YJ; Lee YJ; Kim CH; Lee S; Choung DH; Han DC; Kwon BM
Bioorg Med Chem Lett; 2018 Aug; 28(14):2566-2572. PubMed ID: 29807795
[TBL] [Abstract][Full Text] [Related]
36. Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy.
Chen H; Yang Z; Ding C; Chu L; Zhang Y; Terry K; Liu H; Shen Q; Zhou J
Eur J Med Chem; 2013 Apr; 62():498-507. PubMed ID: 23416191
[TBL] [Abstract][Full Text] [Related]
37. Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway.
Lin L; Lu W; Dai T; Chen H; Wang T; Yang L; Yang X; Liu Y; Sun D
Bioorg Chem; 2021 Jan; 106():104496. PubMed ID: 33288320
[TBL] [Abstract][Full Text] [Related]
38. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain.
Page BD; Fletcher S; Yue P; Li Z; Zhang X; Sharmeen S; Datti A; Wrana JL; Trudel S; Schimmer AD; Turkson J; Gunning PT
Bioorg Med Chem Lett; 2011 Sep; 21(18):5605-9. PubMed ID: 21788134
[TBL] [Abstract][Full Text] [Related]
39. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
[TBL] [Abstract][Full Text] [Related]
40. Discovery of P3971 an orally efficacious novel anticancer agent targeting HIF-1α and STAT3 pathways.
Godse P; Kumar P; Yewalkar N; Deore V; Lohar M; Mundada R; Padgaonkar A; Manohar S; Joshi A; Bhatia D; Desai N; Damre A; Bhonde M; Joshi K; Sharma R; Kumar S
Anticancer Agents Med Chem; 2013 Nov; 13(9):1460-6. PubMed ID: 24102269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]